Detalles de la búsqueda
1.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914339
2.
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 24(2): 162-174, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623515
3.
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Support Care Cancer
; 29(5): 2509-2517, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929540
4.
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Lancet Oncol
; 21(12): 1589-1601, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125909
5.
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events.
Health Qual Life Outcomes
; 17(1): 146, 2019 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31438967
6.
Estimating global treatment toxicity burden from adverse-event data.
Cancer
; 124(4): 858-864, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29112232
7.
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.
J Clin Oncol
; : JCO2302344, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833643
8.
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer.
JCO Precis Oncol
; 7: e2200372, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634296
9.
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
Clin Cancer Res
; 29(18): 3641-3649, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37233987
10.
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).
Clin Cancer Res
; 28(17): 3752-3760, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713632
11.
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Clin Lung Cancer
; 22(4): 313-323.e1, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33745865
12.
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760).
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34429332
13.
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
Clin Lung Cancer
; 22(3): 187-194.e1, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583720
14.
Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403.
J Clin Oncol
; 38(34): 4076-4085, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021871
15.
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.
Clin Cancer Res
; 25(20): 6089-6097, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31358544
16.
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
J Thorac Oncol
; 14(10): 1853-1859, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302234
17.
Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
J Clin Oncol
; 37(28): 2537-2547, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31386610
18.
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
J Thorac Oncol
; 14(10): 1847-1852, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195180
19.
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).
J Thorac Oncol
; 14(10): 1839-1846, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158500
20.
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
Clin Lung Cancer
; 19(1): 84-92, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28801183
Resultados
1 -
20
de 20
1
Próxima >
>>